Cancer patients can respond very differently to the same treatment, while current testing may not reliably identify the therapy most likely to work for each tumor.
R&D Focus
Predicting Med offers diagnostic, prognostic, and theranostic services allowing the implementation of personalized medicines
Innovative Solution
Predicting Med offers diagnostic, prognostic, and theranostic services allowing the implementation of personalized medicines. Predicting Med is at the origin of the Pancreas View molecular test, delivering a prognosis and a theranostic in pancreatic cancers.
Investment Funding
Last Funding Stage
Non-equity Assistance
Last Funding Date
01-07-2021
Lead Investors
Incubateur Impulse
About
Predicting Med offers diagnostic, prognostic, and theranostic services allowing the implementation of personalized medicines. Predicting Med is at the origin of the Pancreas View molecular test, delivering a prognosis and a theranostic in pancreatic cancers. It was founded in 2021 and is located in Marseilles, Provence
Something missing or incorrect on this page? Help us enrich this information
